Drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are five reported by Becker's Hospital Review in the last week:

GoodRx, a prescription savings website, will now offer low-priced online medical visits.

GlaxoSmithKline, the original branded maker of branded Zantac, halted global distribution of its heartburn medicine, according to Bloomberg. 

California released data showing drug prices rose about four times faster than the rate of inflation annually since 2017.

Consumer genetics company 23andMe is partnering with TrialSpark to help accelerate the pace, quality and experience of clinical trials, according to STAT. 

Apotex, a drugmaker headquartered in Canada, is recalling all of its heartburn medicines containing ranitidine from the U.S., after a potentially cancer-causing impurity was found in them. 

The FDA has approved Jynneos, a smallpox and monkeypox live and nonreplicating vaccine. 

Pharmacy deserts are increasingly an issue across the U.S., according to Drug Topics.

President Donald Trump is putting pressure on his party to come up with a plan to lower drug costs as House Democrats move quickly to advance their proposals, according to Politico.

Bayer will invest more than $30 million over the next five years to open a lab in Boston's Brigham and Women's Hospital to develop drugs to treat chronic lung diseases, according to The Boston Globe.